关注
Davide Maria Ferraris
Davide Maria Ferraris
在 uniupo.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB
HH Niemann, V Jäger, PJG Butler, J van den Heuvel, S Schmidt, ...
Cell 130 (2), 235-246, 2007
1972007
Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity
A Wilk, F Hayat, R Cunningham, J Li, S Garavaglia, L Zamani, DM Ferraris, ...
Scientific reports 10 (1), 651, 2020
772020
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
R Miggiano, M Rizzi, DM Ferraris
Pathogens 9 (5), 385, 2020
762020
Ligand-mediated dimerization of the Met receptor tyrosine kinase by the bacterial invasion protein InlB
DM Ferraris, E Gherardi, Y Di, DW Heinz, HH Niemann
Journal of molecular biology 395 (3), 522-532, 2010
592010
Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells
MS Dietz, D Haße, DM Ferraris, A Göhler, HH Niemann, M Heilemann
BMC biophysics 6, 1-9, 2013
562013
Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells
L Quattrini, ELM Gelardi, V Coviello, S Sartini, DM Ferraris, M Mori, ...
Journal of Medicinal Chemistry 63 (9), 4603-4616, 2020
542020
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside …
M Paolino, M Brindisi, A Vallone, S Butini, G Campiani, C Nannicini, ...
ChemMedChem 13 (5), 422-430, 2018
422018
Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
DM Ferraris, R Miggiano, F Rossi, M Rizzi
Pathogens 7 (1), 17, 2018
412018
Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity
DM Ferraris, D Sbardella, A Petrera, S Marini, B Amstutz, M Coletta, ...
Journal of Biological Chemistry 286 (37), 32475-32482, 2011
412011
The synthesis of kynurenic acid in mammals: An updated kynurenine aminotransferase structural KATalogue
F Rossi, R Miggiano, DM Ferraris, M Rizzi
Frontiers in molecular biosciences 6, 7, 2019
402019
Expanding benzoxazole-based inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitor structure–activity as potential antituberculosis agents
S Chacko, HIM Boshoff, V Singh, DM Ferraris, DR Gollapalli, M Zhang, ...
Journal of medicinal chemistry 61 (11), 4739-4756, 2018
402018
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro
ELM Gelardi, G Colombo, F Picarazzi, DM Ferraris, A Mangione, ...
Cancers 13 (2), 356, 2021
362021
Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates
A Petrera, B Amstutz, M Gioia, J Hähnlein, A Baici, P Selchow, ...
Biological chemistry 393 (7), 631-640, 2012
332012
Structures of citrate synthase and malate dehydrogenase of Mycobacterium tuberculosis
DM Ferraris, R Spallek, W Oehlmann, M Singh, M Rizzi
Proteins: Structure, Function, and Bioinformatics 83 (2), 389-394, 2015
322015
Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis
S Donini, DM Ferraris, R Miggiano, A Massarotti, M Rizzi
Scientific reports 7 (1), 1180, 2017
302017
Synthesis and structure–activity relationship of 1-(5-isoquinolinesulfonyl) piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH
V Singh, A Pacitto, S Donini, DM Ferraris, S Boros, E Illyés, B Szokol, ...
European journal of medicinal chemistry 174, 309-329, 2019
282019
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor
M Mori, F Moraca, D Deodato, DM Ferraris, P Selchow, P Sander, M Rizzi, ...
Bioorganic & medicinal chemistry letters 24 (11), 2508-2511, 2014
282014
Hit discovery of Mycobacterium tuberculosis inosine 5′-monophosphate dehydrogenase, GuaB2, inhibitors
NU Sahu, V Singh, DM Ferraris, M Rizzi, PS Kharkar
Bioorganic & medicinal chemistry letters 28 (10), 1714-1718, 2018
272018
Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis
S Donini, S Garavaglia, DM Ferraris, R Miggiano, S Mori, K Shibayama, ...
PLoS One 12 (4), e0175815, 2017
232017
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl) rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1
M Mori, D Deodato, M Kasula, DM Ferraris, A Sanna, A De Logu, M Rizzi, ...
Bioorganic & Medicinal Chemistry Letters 28 (4), 637-641, 2018
222018
系统目前无法执行此操作,请稍后再试。
文章 1–20